Griscelli's Syndrome: Clinical and Immunological Features of Two Siblings.
Patıroğlu T, Özdemir MA, Patıroğlu TE.
Turk J Haematol. 2000 Jun 5;16(4):85-7.
Griscelli's syndrome: clinical features of three siblings.
Sanal O, Küçükali T, Ersoy F, Tinaztepe K, Göğüş S.
Turk J Pediatr. 1993 Apr-Jun;35(2):115-9.
Bone marrow transplantation (BMT) for the syndrome of pigmentary dilution and lymphohistiocytosis (Griscelli's syndrome).
Schneider LC, Berman RS, Shea CR, Perez-Atayde AR, Weinstein H, Geha RS.
J Clin Immunol. 1990 May;10(3):146-53. doi: 10.1007/BF00917914.
Human herpesvirus-6 (HHV-6)-associated necrotizing encephalitis in Griscelli's syndrome.
Wagner M, Müller-Berghaus J, Schroeder R, Sollberg S, Luka J, Leyssens N, Schneider B, Krueger GR.
J Med Virol. 1997 Nov;53(3):306-12. doi: 10.1002/(sici)1096-9071(199711)53:3<306::aid-jmv21>3.0.co;2-d.
Neuroimaging abnormalities in Griscelli's disease.
Sarper N, Akansel G, Aydoğan M, Gedikbaşi D, Babaoğlu K, Gökalp AS.
Pediatr Radiol. 2002 Dec;32(12):875-8. doi: 10.1007/s00247-002-0752-1. Epub 2002 Jul 17.
Myosin Va controls oligodendrocyte morphogenesis and myelination.
Sloane JA, Vartanian TK.
J Neurosci. 2007 Oct 17;27(42):11366-75. doi: 10.1523/JNEUROSCI.2326-07.2007.
Analysis of the interactions between Rab GTPases and class V myosins.
Lindsay AJ, Miserey-Lenkei S, Goud B.
Methods Mol Biol. 2015;1298:73-83. doi: 10.1007/978-1-4939-2569-8_6.
Lymphohistiocytosis: a multi-factorial syndrome of macrophagic activation clinico-pathological study of 38 cases.
Goldberg J, Nezelof C.
Hematol Oncol. 1986 Oct-Dec;4(4):275-89. doi: 10.1002/hon.2900040405.
